After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, EOLS falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Evolus Inc is $432.75M. A total of 0.99 million shares were traded on the day, compared to an average of 1.41M shares.
In the most recent transaction, Stewart Brady bought 30,000 shares of EOLS for 6.82 per share on Aug 15 ’25. After the transaction, the Director now owns 88,629 company shares. In a previous transaction on Jun 13 ’25, MOATAZEDI DAVID sold 111,323 shares at 10.05 per share. EOLS shares that the insider owns now total 381,509.
Among the insiders who sold shares, MOATAZEDI DAVID disposed of 16,582 shares on Jun 16 ’25 at a per-share price of $9.89. This resulted in the insider holding 364,927 shares of EOLS after the transaction. In another insider transaction, DAVID MOATAZEDI bought 16,582 shares at $9.89 per share on Jun 16 ’25.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, EOLS has a high of $17.82 and a low of $5.71.
As of this writing, EOLS has an earnings estimate of -$0.16 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.12 per share and a lower estimate of -$0.18. The company reported an EPS of -$0.18 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. EOLS’s latest balance sheet shows that the firm has $146.26M in Cash & Short Term Investments as of fiscal 2021. There were $74.74M in debt and $57.66M in liabilities at the time. Its Book Value Per Share was -$0.29, while its Total Shareholder’s Equity was $81.88M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EOLS is Buy with a score of 4.67.